Myosin divers In the human epi cell line Caco-2Ba, the porcine pihal Cell line LLC PK1 (CL-4)9
screening demonstrated that the inal PCR products correspond to bona fide myosins, based on the presence of sequences highly conserved in other myosins. RNase protection analysis confirmed mRNA expression of 11 myosins in Caco-2B&3 cells.
Immunoblot analysis showed that at least 6 myosin immunogens are expressed in Caco-2BB. cells. The results reveal the existence of at least 11 unconventional human myosin genes, most of which are expes in an overilapping fashion in different cell types. The abundance of myosin suggests that the myosin I vs. myosin II paradin is inadequate to explain actin-based cellular motility.
Eukaryotes display a broad array of motility phenomena, ranging from muscle-driven movement to translocation of intracellular organelles. The mechanisms underlying these phenomena are not entirely clear, but it is generally thought that "molecular motors," such as kinesins, dyneins, and myosins, act at cytoskeletal-cytoskeletal and cytoskeletalmembrane interfaces to power organism and cellular movements (1) (2) (3) (4) . These motors are represented by multiple members in eukaryotes (4, 5) , each of which is presumed to play one or more roles during the life of the organism. For example, the fruit fly is known to have at least 6 (6) and possibly as many as 30 (7) kinesins. A unicellular organism, Dictyostelium discoideum, has a minimum offive myosins (8, 9) and probably more than nine (10, 47) .
Thus, within an organism, multiple diverse molecular motors are the rule. For myosins, phylogenetic analyses have revealed the existence of eight classes (11) (12) (13) , termed either conventional (filament-forming myosins II) or unconventional (apparently nonfilamentous myosins I and III-VIII) (14) . Although evidence indicates that many ofthe unconventional myosin classes will be represented in a given organism (5, 15) , to our knowledge, in no case has the number of myosins expressed in a metazoan cell type been determined. Consequently, studies concerning actin-based motility in metazoan cells are complicated by limited information on cellular myosin diversity. We therefore analyzed myosin diversity in two epithelial cell lines, Caco2BBe (16) Screening. Caco-2BBe cells were cultured as described (16) . LLC-PK1 (CL-4) cells were obtained from C. Slayman (Yale University), cultured in minimum essential medium, a modification (GIBCO/BRL)/10% (vol/vol) fetal calf serum/2% (wt/vol) glutamine (Sigma) and penicillin 100 (units/ml)/streptomycin (100 t.g/ml)/fungizone (0.25 pug/ ml) (JRH Biosciences, Lenexa, KS), and used at 4 days after confluence. Peripheral blood leukocytes were purified from whole blood of human volunteers via density gradient cell separation (18) . RNA was isolated by guanidinium lysis followed by a CsCl gradient (19) . cDNAs were generated using reverse transcriptase (New England Biolabs). For PCR of liver cDNAs, a AZAP cDNA library (Stratagene) prepared from normal human liver (a gift from James Mustafa Anderson, Yale University) was employed. Myosins were amplified from cDNAs using standard PCR techniques (20) . Two degenerate myosin primers, "ATP-3"
, were designed based on the myosin consensus sequence (2) . ATP-3 corresponds to the amino acid sequence GESGAGKT, a sequence found in all myosins (e.g., aa 163-170 in avian myosin V; ref. 21) , and EAF-A corresponds to EAFGNAKT, a sequence found in most myosins. After amplification, products were separated on NuSieve (FMC) agarose gels, excised from the gel, and reamplified by PCR. After the second amplification, products were separated on agarose gels and purified on DEAE-cellulose paper. Purified products were ligated into T-modified Bluescript vector (22) and transformed into competent bacteria (XL1-Blue, Stratagene). Plasmid minipreps (23) were performed and insert presence was confirmed by restriction analysis. Inserts were sequenced with a kit (United States Biochemical). Larger clones were obtained by hybridization screening of the human liver library with a subset offour ofthe subcloned PCR products. Plasmid inserts were labeled with 32P by using random priming (Boehringer Mannheim). Positive plaques were isolated and converted to phagemid by in vivo excision.
Expressio Analysis. RNase protection probes were generated using subcloned PCR products. Antisense [32P]UTP and rCTP-labeled RNA were transcribed from plasmids using T3 or T7 RNA polymerase. Probes were hybridized with 20 tig of total Caco-2BB. RNA, digested with RNases A and T1 (19) , and separated on 8% polyacrylamide gels, using endlabeled A DNA digested with Hinfl as size markers. Because Abbreviations: HuncM, human unconventional myosin; HConM, human conventional myosin; PuncM, porcine unconventional myosin; PConM, porcine conventional myosin. ' The sequences reported in this paper have been deposited in the GenBank data base (accession nos. L29137-L29149 for human unconventional myosins and L29128-L29136 for porcine unconventional myosins).
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Proc. Nail. Acad. Sci. USA 91 (1994) probes were derived from PCR products containing inosine residues at their 5' and 3' ends and because primer matching need not be exact for amplification, two complications must be considered. (i) The probes were heterogenous at their ends, thus, protected products often resolved as several bands on autoradiographs. (ii) It was not possible to predict the exact size of protected products; rather, size predictions were limited to the range, with the region between the primers defining the lower limit (90-120 bp) and this region plus the primers defining the upper limit (136-166 bp). Nevertheless, RNase protection using degenerate PCR products provides a reproducible and sensitive means to assess myosin RNA expression (24) .
Flasks containing Caco-2BBe cells were rinsed with TBS (150 mM NaCI/50 mM Tris'HCI, pH 7.4), scraped into a polypropylene tube, pelleted, and homogenized in SDS sample buffer. Samples were separated on 5-15% polyacrylamide gels, electroblotted to nitrocellulose (16) (25), affinity-purified antichicken myosin V antibodies (21), or affinity-purified antiporcine myosin VI antibody (26) .
RESULTS

PCR Analysis of Myosin Diversity In Human and Porcine
Cells. To assess myosin diversity, PCR amplification of myosin-like sequences was performed using the human epithelial cell line Caco-2BBe (16, 27) . This clonally derived line was selected based on its resemblance to normal human intestinal epithelia (16, 24, 28) . PCR amplification yielded 10 products that bore various degrees of homology to known human and mammalian myosins (Fig. 1A ). Products were grouped into five previously identified classes (myosins 1, 11, V, VI, and VII) and a sixth group (myosin IX) that bore no similarity to any known myosin class. Most classes had at least two representatives, and, based on the nucleotide sequences that differed along the length of the products, all of the sequences, except HConM-IIA', appeared to be prod- To determine whether the myosins were cell-type-specific, PCR analysis of myosin diversity was also conducted using human peripheral blood leukocyte cDNAs or a human liver cDNA library as starting material. Most of the myosin PCR products identified in Caco-2BBC cells were also found in leukocytes and liver (Fig. 1A) . Because the leukocyte and liver cDNAs represent several cell types, myosin diversity in the LLC-PK1 cell line was determined. As in the human cells, six groups of PCR products were identified in LLC-PK1, including myosins IX (Fig. iB) . Porcine myosin IX products bore no homology to known myosins but were nearly identical to human myosin IXs obtained by PCR.
Confirmation of PCR Products as Myosins. The foregoing results suggested that vertebrate cell types express multiple myosins, most of which are not cell-type specific. It was essential, however, to demonstrate that the PCR products correspond to larger myosin sequences. Specifically, the presence of the canonical myosin sequences, GESGAGKT and EAFGNAKT, upon which the PCR primers were based, had to be independently confirmed, since any PCR-amplified products will necessarily contain these sequences. This was accomplished by screening a human liver cDNA library with four of the PCR products, including the least "myosin-like" (myosins IX). Six myosin-like sequences were thereby obtained, five (HuncM-IB, HuncM-IC, HuncM-VI, HuncM-IXA, and HuncM-IXB) that correspond to myosins identified by PCR and one (HuncM-ID) that was not found by PCR (Fig.  2) . HuncM-ID was 96% identical to HuncM-IC (amino acids), but scattered nucleotide differences (85% identity) along the length of the two clones indicate that they are distinct gene products. All of the larger clones were similar to known myosins (Fig. 2) , with the exception of the myosins IX. For example, HuncM-VI had 100%/ amino acid identity with PuncM-VI (95% nucleotide identity; ref. 26) and HuncM-IB was 100% identical to a mouse myosin I, MMIa (30) , and 98% identical to a rat myosin I, myrIc (37) . Further, all of the clones, including the myosins IX, possessed perfect or nearly perfect GESGAGKT and EAFGNAKT sequences (Fig. 2) .HuncM-TXE PCR products were found to be expressed by Caco-2BBe cells, as demonstrated by protection of RNA within the predicted size range (Fig. 3). (One of the products, HConM-IIA', gave a strong signal at a size smaller than predicted, possibly due to a Taq polymerase error in the original amplification.) HuncM-IB, which was not detected by PCR in Caco-2BB. cells, was nevertheless expressed in Caco-2BB. cells as assessed by RNase protection (Fig. 3) and HuncM-IXB, which was not detected by PCR or RNase protection, was identified by Northern blot analysis of total Caco-2BB. RNA (Table 1) . Likewise, all myosin PCR products identified in LLC-PK1 cells were also detected by RNase protection (data not shown). To confirm that the multiple bands in the RNase protection assays reflected the presence of "ragged ends" arising from inosines in the PCR products, a portion of a myosin VI cDNA obtained by library screening was used for RNase protection. This yielded a single band of exactly the predicted size (data not shown), confirming the validity ofthe use of degenerate PCR products for RNase protection.
To further assess myosin diversity in Cac0-2BBe cells, monolayer extracts were examined by immunoblot analysis.
As previously shown (16, 24) , Caco-2BBe cells express at least one myosin II and three myosin I immunogens of 140, 130, and 110 kDa (Fig. 4) . In addition, immunoblot analysis with antibodies against avian myosin V (21) (16, 24) 
